Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries
Eur Respir J
.
2023 Oct 19;62(4):2300556.
doi: 10.1183/13993003.00556-2023.
Print 2023 Oct.
Authors
Kaila Aguiar Soares
1
,
Joanna Ehrlich
1
,
Miguel Camará
2
,
Souleymane Chaloub
3
,
Elom Emeka
4
,
Hervé Gildas Gando
5
,
Farzana Ismail
6
,
Lindiwe Mvusi
7
,
Thulani Jele
8
,
Benedita José
9
,
Botshelo Kgwaadira
10
,
Riziki Kisonga
11
,
Taye Letta
12
,
Aubin Oyongo Liega
13
,
Patrick Saili Lungu
14
,
Llang Maama
15
,
Jocelyn Mahoumbou
16
,
Kuzani Mbendera
17
,
Jeremiah Ogoro
18
,
Daniel Alphonse Désiré Tollo
19
,
Charles Sandy
20
,
Rufus G Saye
21
,
Jacob Sheehama
22
,
Sissy Musala
23
,
Didas Tugumisirize
24
,
Lucia Carratala
1
,
Marta Cossa
25
,
Alberto L Garcia-Basteiro
26
25
27
Affiliations
1
ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain.
2
Programa Nacional de Luta Contra Lepra e Tuberculose, Bissau, Guinea-Bissau.
3
Guinée Médecins Sans Frontières, Conakri, Guinea.
4
National Tuberculosis and Leprosy Control Programme, Abuja, Nigeria.
5
Service de Lutte Contre la Tuberculose, Bangui, Central African Republic.
6
Centre for Tuberculosis, National Institute for Communicable Diseases/National Health Laboratory Services, Johannesburg, South Africa.
7
TB Control and Management, National Department of Health, Pretoria, South Africa.
8
National Tuberculosis Control Programme, Manzini, Eswatini.
9
Programa Nacional de Controlo da Tuberculose, Maputo, Mozambique.
10
Botswana National Tuberculosis Programme, Gaborone, Botswana.
11
National Tuberculosis and Leprosy Programme, Dar Es Salaam, United Republic of Tanzania.
12
National Tuberculosis and Leprosy Programme, Addis Ababa, Ethiopia.
13
Programme National de Lutte Contre la Tuberculose, Brazzaville, Congo.
14
National Tuberculosis and Leprosy Control Programme, Lusaka, Zambia.
15
National Tuberculosis and Leprosy Programme, Maseru, Lesotho.
16
Programme National de Lutte Contre la Tuberculose, Libreville, Gabon.
17
National Tuberculosis Control Programme, Lilongwe, Malawi.
18
National Tuberculosis, Leprosy and Lung Disease Programme, Nairobi, Kenya.
19
Programme National de Lutte Contre la Tuberculose, Yaoundé, Cameroon.
20
Ministry of Health and Child Care, Harare, Zimbabwe.
21
National Leprosy and Tuberculosis Control Programme, Monrovia, Liberia.
22
University of Namibia, Windhoek, Namibia.
23
Programme National de Lutte Contre la Tuberculose, Kinshasa, Democratic Republic of the Congo.
24
Ministry of Health - National Tuberculosis Reference Laboratory, Kampala, Uganda.
25
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique.
26
ISGlobal - Barcelona Institute for Global Health, Barcelona, Spain alberto.garcia-basteiro@manhica.net.
27
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
PMID:
37802630
DOI:
10.1183/13993003.00556-2023
No abstract available
Publication types
Letter
MeSH terms
HIV Infections* / complications
HIV Infections* / diagnosis
Humans
Lipopolysaccharides
Sensitivity and Specificity
Tuberculosis* / diagnosis
Tuberculosis* / epidemiology
World Health Organization
Substances
Lipopolysaccharides